Lee Ha-yi Wraps Up Solo Concert to Great Success… Performs Hit Songs Including “Sigh”
At the NOL Theater, Dongyang Life Hall in Hapjeong
Connecting with the audience that filled the auditorium
Performances of new songs such as “Up” and “Two Easy”
[Edaily Starin KIM HYUNSIK Reporter] Singer Lee Hi successfully wrapped up her solo concert. Scene from Lee Hi’s solo concert (Photo courtesy of 808 HI RECORDINGS)According to her agency, 808 HI RECORDINGS, on the 6th, Lee Hi held her solo concert “HI-biscus Garden Live vol. 1” on the 3rd at the Dongyang Life Hall in the NOL Theater in Hapjeong, Mapo-gu, Seoul. Lee Hi kicked off the concert with “Rose” and went on to perform her hit songs, including “Savior,” “Safe Zone,” “Your Intentions,” “Red Lipstick,” “1, 2, 3, 4,” “Sigh,” “Only,” and “I’m Different.” Lee Hi, who has long been beloved for her R&B and ballad music, delighted the packed audience by blending her uniquely soulful yet rhythmic vocals with the live band’s performance. She also performed her new songs. Lee Hi sang “UP,” “2 EASY,” and “HON2ST” live. Toward the end of the concert, she shared memories with the audience by taking commemorative photos and received cheers from fans when she unveiled the music video for her upcoming single “KAI.” Lee Hi made her official debut in 2012 after appearing on the SBS music survival show “K-Pop Star.” She continues her activities through the music label 808Hi Recordings, which she co-founded with rapper Dok2, with whom she is publicly dating.
As the Japanese government moves forward with plans to incorporate crypto assets into the framework of the Financial Instruments and Exchange Act (hereinafter referred to as the FIEA), the government …
curacle co., ltd.(365270)is moving forward with a U.S. Phase 2b clinical trial to develop an oral treatment for diabetic macular edema (DME). The trial will re-evaluate the treatment’s efficacy in pat…
#Aimed Bio Inc.’s antibody-drug conjugate (ADC) “BHV-1530 (AMB302),” which was licensed to U.S.-based Biohaven, has demonstrated initial anticancer efficacy in a Phase 1 clinical trial. Biohaven plans…